These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29125062)

  • 1. Drug delivery during pregnancy: how can nanomedicine be used?
    Joshi MD
    Ther Deliv; 2017 Dec; 8(12):1023-1025. PubMed ID: 29125062
    [No Abstract]   [Full Text] [Related]  

  • 2. Dynamic placenta-on-a-chip model for fetal risk assessment of nanoparticles intended to treat pregnancy-associated diseases.
    Shojaei S; Ali MS; Suresh M; Upreti T; Mogourian V; Helewa M; Labouta HI
    Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166131. PubMed ID: 33766738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal drug delivery systems: from concept to clinical applications.
    Allen TM; Cullis PR
    Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Could peptide-decorated nanoparticles provide an improved approach for treating pregnancy complications?
    Harris LK
    Nanomedicine (Lond); 2016 Sep; 11(17):2235-8. PubMed ID: 27487963
    [No Abstract]   [Full Text] [Related]  

  • 5. Nanomedicine for Maternal and Fetal Health.
    Carter D; Better M; Abbasi S; Zulfiqar F; Shapiro R; Ensign LM
    Small; 2024 Oct; 20(41):e2303682. PubMed ID: 37817368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actively Targeted Nanomedicines: A New Perspective for the Treatment of Pregnancy-Related Diseases.
    Yang H; Wang S
    Reprod Sci; 2024 Sep; 31(9):2560-2575. PubMed ID: 38553575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine: sizing up targets with nanoparticles.
    Minchin R
    Nat Nanotechnol; 2008 Jan; 3(1):12-3. PubMed ID: 18654442
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticancer drug delivery with nanoparticles.
    Conti M; Tazzari V; Baccini C; Pertici G; Serino LP; De Giorgi U
    In Vivo; 2006; 20(6A):697-701. PubMed ID: 17203748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-based nanomedicine platforms for drug delivery.
    Maham A; Tang Z; Wu H; Wang J; Lin Y
    Small; 2009 Aug; 5(15):1706-21. PubMed ID: 19572330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine.
    Kim NJ; Harris A; Gerber A; Tobe LA; Amireskandari A; Huck A; Siesky B
    Br J Ophthalmol; 2014 Apr; 98(4):427-31. PubMed ID: 24246373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnological Strategies for Protein Delivery.
    Villegas MR; Baeza A; Vallet-Regí M
    Molecules; 2018 Apr; 23(5):. PubMed ID: 29693640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanovesicles for Nanomedicine: Theory and Practices.
    Wadhwa S; Garg V; Gulati M; Kapoor B; Singh SK; Mittal N
    Methods Mol Biol; 2019; 2000():1-17. PubMed ID: 31148004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface-Functionalized Nanoparticles as Efficient Tools in Targeted Therapy of Pregnancy Complications.
    Zhang B; Liang R; Zheng M; Cai L; Fan X
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31349643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploiting the placenta for nanoparticle-mediated drug delivery during pregnancy.
    Figueroa-Espada CG; Hofbauer S; Mitchell MJ; Riley RS
    Adv Drug Deliv Rev; 2020; 160():244-261. PubMed ID: 32956719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Application of Engineered Nanomaterials in Perinatal Therapeutics.
    Stapleton PA
    Small; 2024 Oct; 20(41):e2303072. PubMed ID: 37438678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications.
    Al-Jamal WT; Kostarelos K
    Nanomedicine (Lond); 2007 Feb; 2(1):85-98. PubMed ID: 17716195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface-active liposomes for targeted cancer therapy.
    Sofou S
    Nanomedicine (Lond); 2007 Oct; 2(5):711-24. PubMed ID: 17976032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Native and Reconstituted Plasma Lipoproteins in Nanomedicine: Physicochemical Determinants of Nanoparticle Structure, Stability, and Metabolism.
    Pownall HJ; Rosales C; Gillard BK; Ferrari M
    Methodist Debakey Cardiovasc J; 2016 Sep; 12(3):146-150. PubMed ID: 27826368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational Design of Nanomedicine for Placental Disorders: Birthing a New Era in Women's Reproductive Health.
    Geisler HC; Safford HC; Mitchell MJ
    Small; 2024 Oct; 20(41):e2300852. PubMed ID: 37191231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine and veterinary science: the reality and the practicality.
    Underwood C; van Eps AW
    Vet J; 2012 Jul; 193(1):12-23. PubMed ID: 22365842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.